Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-10-001404
Filing Date
2010-03-12
Accepted
2010-03-12 16:08:21
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 c60623_10k.htm 10-K 1511726
2 GRAPHIC c56802enzonlogok.jpg GRAPHIC 4515
3 GRAPHIC c60623linechart.jpg GRAPHIC 20441
4 c60623_ex12-1.htm EX-12.1 36064
5 c60623_ex21-1.htm EX-21.1 2459
6 c60623_ex23.htm EX-23 2010
7 c60623_ex31-1.htm EX-31.1 11941
8 c60623_ex31-2.htm EX-31.2 11949
9 c60623_ex32-1.htm EX-32.1 4664
10 c60623_ex32-2.htm EX-32.2 4709
  Complete submission text file 0000930413-10-001404.txt   1621948
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 10677856
SIC: 2836 Biological Products, (No Diagnostic Substances)